Chemistry:Ruplizumab

From HandWiki
Short description: Monoclonal antibody
Ruplizumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetCD154
Clinical data
Trade namesAntova
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 ☒N☑Y (what is this?)  (verify)

Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms,[1] while another study only found thrombocytopenia.[2]

References

  1. "Costimulation blockade in the treatment of rheumatic diseases". BioDrugs 18 (2): 95–102. 2004. doi:10.2165/00063030-200418020-00003. PMID 15046525. 
  2. "Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism". Rheumatology 45 (2): 150–6. February 2006. doi:10.1093/rheumatology/kei118. PMID 16188945.